ScienceTechnical Deep Dive

Common Antidepressant Shows Promise in Easing Long COVID Fatigue

Published

Common Antidepressant Shows Promise in Easing Long COVID Fatigue

1 min read138 words

The Gist

“A recent clinical trial suggests that fluvoxamine, a low-cost antidepressant, could significantly reduce fatigue and improve quality of life for long COVID patients.”

New clinical research offers a potential breakthrough for millions suffering from the persistent exhaustion associated with long COVID. A randomized clinical trial has found that fluvoxamine, a widely available and inexpensive antidepressant, may effectively mitigate the condition's most debilitating symptoms.

Clinical Trial Results

The study involved 399 adults struggling with long COVID fatigue. Participants were divided into groups receiving either fluvoxamine or a placebo. The results indicated that those treated with the medication experienced a significant reduction in fatigue levels and a measurable improvement in their overall quality of life.

A New Tool for Recovery

Fluvoxamine is now among the first medications to demonstrate meaningful clinical benefits for this specific condition. As long COVID continues to impact global health and workforce productivity, these findings provide a much-needed therapeutic lead for clinicians dealing with cases of chronic post-viral fatigue.

Related Stories

Semantically matched articles, ranked by topic overlap and freshness.

Innovative Treadmill Therapy Shows Promise for PTSD Recovery

Innovative Treadmill Therapy Shows Promise for PTSD Recovery

Researchers at the University of Alberta have found that combining physical motion with memory confrontation significantly improves PTSD treatment outcomes.

The Impact of Ultra-Processed Foods on Long-Term Brain Health

The Impact of Ultra-Processed Foods on Long-Term Brain Health

New research highlights a concerning link between ultra-processed diets and increased risks of depression, anxiety, and dementia.

Working Memory Rapidly Re-Prioritizes After Distractions, New Study Reveals

Working Memory Rapidly Re-Prioritizes After Distractions, New Study Reveals

A new study highlights the brain's remarkable ability to swiftly update working memory priorities to maintain focus on immediate tasks despite frequent interruptions.

Ebola Cases Surpass 3,000 in Democratic Republic of Congo Outbreak

Ebola Cases Surpass 3,000 in Democratic Republic of Congo Outbreak

Health officials in the DR Congo report a massive surge in Ebola infections, with cases exceeding 3,000 following a rapid spike in the last 10 days.

Chinese University Probes Alleged Death in Gene-Editing Trial

Chinese University Probes Alleged Death in Gene-Editing Trial

A Chinese university is investigating reports that a 6-year-old girl died during a gene-editing trial, an incident allegedly omitted from published research.

Early Childhood Infections Linked to the Sibling Earnings Gap

Early Childhood Infections Linked to the Sibling Earnings Gap

New research suggests that the lower average earnings of younger siblings may be driven by exposure to respiratory infections brought home by their older brothers and sisters.

Innovative Eye Implant and High-Tech Glasses Approved to Combat Vision Loss

Innovative Eye Implant and High-Tech Glasses Approved to Combat Vision Loss

A breakthrough eye implant and smart glasses system has received European regulatory approval, offering hope to those suffering from severe age-related vision loss.

Mapping the Mind: Two Neural Pathways Explain Habit Formation

Mapping the Mind: Two Neural Pathways Explain Habit Formation

New research identifies the specific brain mechanisms that transition deliberate actions into automatic routines, explaining why some habits feel harder to break than others.